Strategic Partnership
- RegAff wants to build strategic partnerships with Pharma and Biotech companies so that it can deliver more value and more cost effectively. Such partnerships would have a multi-year contract and would provide to companies:
- In a growth phase for a small to medium sized business, an increase in capability without a corresponding, fully allocated fixed cost increase
- Cost efficiency by enabling internal resource to be focused on growth through core business initiatives and using RegAff for routine activities
- Achieve earlier ROI from Asia markets by earlier Marketing Approvals
A way of delivering non-core but important business objectives
- Source of people to recruit
Benefits of Regulatory Partnerships
- Fixed costs become variable costs Ability to invest in in-house in highly skilled competencies
- Enables business growth strategies without risk of too many fixed costs
- Sustainable model of cost efficiency around routine activities
- Information management: leading edge without high fixed cost
- Leading (instead of following) corporate mandates about cost and headcount
There are two areas of Regulatory Affairs where we believe that we can offer substantial cost effectiveness.
- License Maintenance
- Regulatory Operations
|
|